Su, X.

stent patient spirit trial spirit ii follow-up 3 years lesion analysis 3- year outcomes target death stent thrombosis 3- year follow-up stent system event artery lesions reduction study outcome artery thrombosis xience randomized treatment paclitaxel-eluting ef ficacy iii trials jacc everolimu vessel finite signi spirit iii point research paclitaxel-eluting stents eluting iii trials ficacy everolimus-eluting target vessel failure revascularization sirolimus-eluting failure system intervention table evaluation ischemia-driven group ischemia-driven tlr infarction caixeta 1 year safety sirolimus-eluting stents ficant subgroup drug-eluting signi ficant reduction value abbott result end points diabetes xience v december patients randomized artery disease figure bare-metal stents stone signi ficantly investigator month consortium 0.59 patient-level hazard everolimus-eluting stent